Description

5,6,7,8-Tetrahydro-2-Methyl-Imidazo[1,2-A]Pyridin-8-Ol is a heterocyclic organic compound of significant interest in advanced pharmaceutical synthesis. This molecule serves as a critical building block (advanced intermediate) for the development of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D departments and fine chemical manufacturers engaged in creating new therapeutic agents, particularly within the central nervous system and metabolic disorder domains.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the multi-step synthesis of complex drug candidates and novel APIs.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Fine Chemical Synthesis: Employed in the production of specialized, high-value compounds for agrochemical and material science applications.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services for the life sciences industry.
• Academic Research: Utilized in universities and research institutes for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	5,6,7,8-Tetrahydro-2-Methyl-Imidazo[1,2-A]Pyridin-8-Ol
CAS No.	110206-58-1
Molecular Formula	C8H12N2O
Molecular Weight	152.20 g/mol
Synonyms	2-Methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-ol; 8-Hydroxy-2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine; 2-Methyl-8-hydroxy-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine; Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro-2-methyl-; THIP analog intermediate
EINECS	Contact for details

Quality Control

Our production of 5,6,7,8-Tetrahydro-2-Methyl-Imidazo[1,2-A]Pyridin-8-Ol adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure high purity and consistent chemical identity. We provide detailed Certificates of Analysis (COA) with every shipment, documenting all critical quality attributes. Our quality system is designed to support cGMP-compliant applications for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.